CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers.Jung HR, Oh Y, Na D, Min S, Kang J, Jang D, Shin S, Kim J, Lee SE, Jeong EM, An JY, Sung CO, Lee WS, Lee C, Cho SY.Oncogene. 2021 May;40(18):3287-3302. doi: 10.1038/s41388-021-01777-7. Epub 2021 Apr 12.PMID: 33846570